HK1204289A1 - Topical ophthalmological pharmaceutical composition containing cediranib - Google Patents

Topical ophthalmological pharmaceutical composition containing cediranib

Info

Publication number
HK1204289A1
HK1204289A1 HK15104946.0A HK15104946A HK1204289A1 HK 1204289 A1 HK1204289 A1 HK 1204289A1 HK 15104946 A HK15104946 A HK 15104946A HK 1204289 A1 HK1204289 A1 HK 1204289A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical composition
composition containing
ophthalmological pharmaceutical
topical ophthalmological
cediranib
Prior art date
Application number
HK15104946.0A
Other languages
English (en)
Chinese (zh)
Inventor
Michael Bttger
Degenfeld Georges Von
Julia Freundlieb
Claudia Hirth-Dietrich
Joerg Keldenich
Jrgen Klar
Uwe Muenster
Andreas Ohm
Annett Richter
Bernd Riedl
Joachim Telser
Original Assignee
Bayer Healthcare Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2012/062365 external-priority patent/WO2013000917A1/fr
Application filed by Bayer Healthcare Llc filed Critical Bayer Healthcare Llc
Publication of HK1204289A1 publication Critical patent/HK1204289A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK15104946.0A 2012-06-25 2015-05-26 Topical ophthalmological pharmaceutical composition containing cediranib HK1204289A1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
PK40512 2012-06-25
PCT/EP2012/062365 WO2013000917A1 (fr) 2011-06-28 2012-06-26 Composition pharmaceutique topique ophtalmologique contenant du régorafénib
JOP20120170 2012-06-27
VE81612 2012-06-27
EP12198643 2012-12-20
PCT/US2013/044945 WO2013188279A1 (fr) 2012-06-12 2013-06-10 Composition pharmaceutique ophtalmique topique contenant du cediranib

Publications (1)

Publication Number Publication Date
HK1204289A1 true HK1204289A1 (en) 2015-11-13

Family

ID=49758932

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15104946.0A HK1204289A1 (en) 2012-06-25 2015-05-26 Topical ophthalmological pharmaceutical composition containing cediranib

Country Status (7)

Country Link
US (1) US20150165028A1 (fr)
EP (1) EP2863885A1 (fr)
JP (1) JP2015520231A (fr)
CN (1) CN104379128A (fr)
CA (1) CA2877678A1 (fr)
HK (1) HK1204289A1 (fr)
WO (1) WO2013188279A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105461698A (zh) * 2014-09-12 2016-04-06 杭州普晒医药科技有限公司 西地尼布盐及其晶型、以及其制备方法和药物组合物
KR20240043821A (ko) * 2015-06-06 2024-04-03 클라우드브레이크 테라퓨틱스, 엘엘씨 익상편을 치료하기 위한 조성물 및 방법
CA3025325A1 (fr) 2016-06-02 2017-12-07 Cloudbreak Therapeutics, Llc Compositions et procedes d'utilisation de nintedanib pour ameliorer le taux de reussite de la chirurgie du glaucome
CN112237584B (zh) * 2020-08-21 2021-10-01 中国医学科学院医药生物技术研究所 化合物预防和/或治疗冠状病毒感染所致疾病的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS52625B (en) * 2003-07-23 2013-06-28 Bayer Healthcare Llc FLUORO SUBSTITUTED OMEGA-CARBOXYARYL DIPHENYL UREA FOR TREATMENT AND PREVENTION OF DISEASES AND DISEASES
GB0330002D0 (en) * 2003-12-24 2004-01-28 Astrazeneca Ab Quinazoline derivatives
CA2715181A1 (fr) * 2008-02-21 2009-08-27 Astrazeneca Ab Therapie de combinaison 238

Also Published As

Publication number Publication date
CA2877678A1 (fr) 2013-12-19
WO2013188279A8 (fr) 2014-02-06
WO2013188279A1 (fr) 2013-12-19
CN104379128A (zh) 2015-02-25
US20150165028A1 (en) 2015-06-18
EP2863885A1 (fr) 2015-04-29
JP2015520231A (ja) 2015-07-16

Similar Documents

Publication Publication Date Title
ZA201703992B (en) Inhalable pharmaceutical compositions
HK1205690A1 (en) Pharmaceutical composition and administration thereof
HK1204564A1 (en) Topical ophthalmological pharmaceutical composition containing axitinib
HK1214170A1 (zh) 含有瑞戈非尼的包衣的藥物組合物
ZA201501930B (en) Pharmaceutical composition
HK1204563A1 (en) Topical ophthalmological pharmaceutical composition containing pazopanib
EP2832730A4 (fr) Composition pharmaceutique contenant du mirabegron
HK1204992A1 (en) Topical ophthalmological pharmaceutical composition containing sunitinib
ZA201405949B (en) Pharmaceutical preparation containing and antivirally active dihydroquinazoline derivative
HK1197176A1 (en) Topical ophthalmological pharmaceutical composition containing regorafenib
HK1210711A1 (en) Pharmaceutical composition comprising rebamipide
HK1204289A1 (en) Topical ophthalmological pharmaceutical composition containing cediranib
ZA201505196B (en) Topical ophthalmological pharmaceutical composition containing regorafenib
ZA201502987B (en) Pharmaceutical composition
EP2851074A4 (fr) Composition pharmaceutique analgésique
EP2859885A4 (fr) Composition pharmaceutique antibactérienne
EP2883546A4 (fr) Nouvelle composition pharmaceutique à libération différentielle contenant trois principes actifs
EP2897590A4 (fr) Composition pharmaceutique
HK1204945A1 (en) Pharmaceutical formulation containing flupirtin
EP2851078A4 (fr) Composition pharmaceutique
ZA201400751B (en) Pharmaceutical composition
GB201204597D0 (en) Topical pharmaceutical formulation
GB201221130D0 (en) New pharmaceutical composition
GB201207628D0 (en) New pharmaceutical composition
GB201207701D0 (en) New pharmaceutical composition